41 results
8-K
EX-99.1
KPRX
Kiora Pharmaceuticals Inc
25 Mar 24
Results of Operations and Financial Condition
7:03am
with a partner who has a proven track-record of leadership in the eye space. Working with TOI, we are finalizing details of the randomized, double
8-K
EX-99.1
KPRX
Kiora Pharmaceuticals Inc
12 Feb 24
Regulation FD Disclosure
5:23pm
, CPA EVP – Finance Stefan Sperl, PhD EVP – CMC & Operations Leadership Team
41 Board of Directors Brian M Strem, PhD President & CEO Aron Shapiro Ken
8-K
EX-99.1
KPRX
Kiora Pharmaceuticals Inc
9 Nov 23
Regulation FD Disclosure
7:02am
EVP – CMC & Opera7ons Leadership Team
36 Board of Directors Brian M. Strem, PhD President & CEO Aron ShapiroKen Gayron Praveen Tyle, PhD Chairman
8-K
EX-99.1
6icsm8nig
21 Sep 23
Kiora Pharmaceuticals Appoints Praveen Tyle, PhD, as New Chairman; Succeeds Paul Chaney Who is Retiring After Serving 17 Years
7:00am
FWP
q02xw4cz s90dwy11sg
15 May 23
Free writing prospectus
5:18pm
8-K
EX-99.1
ra0gxp4clw
16 Sep 22
Kiora Pharmaceuticals Appoints Melissa Tosca as Executive Vice President of Finance
4:30pm
8-K
oi1eaywap8ndas
16 Sep 22
Kiora Pharmaceuticals Appoints Melissa Tosca as Executive Vice President of Finance
4:30pm
FWP
3v4numbi37vfu
14 Jul 22
Free writing prospectus
5:14pm
8-K
EX-99.1
w6c91qsy3jxu
1 Feb 22
Kiora Pharmaceuticals Appoints Erin Parsons to its Board of Directors; Stephen From to Retire from Board
6:45am
8-K
EX-99.1
7ue i7n66wid
11 Jan 22
Regulation FD Disclosure
12:00am
8-K
EX-99.1
1zdd4ydxha 0hq63059u
15 Dec 21
Kiora Pharmaceuticals Appoints David Hollander, MD, MBA, to its Board of Directors
7:00am
8-K
t2g0f1tufa
15 Dec 21
Kiora Pharmaceuticals Appoints David Hollander, MD, MBA, to its Board of Directors
7:00am
8-K
EX-99.1
m9nll00wkax7sm114
26 Oct 21
EyeGate adds Bayon Therapeutics’ portfolio of vision-restoring small molecules to its development pipeline
7:00am